Nevertheless, it is worth noting that intratumoral administration of IL-33 was as efficient as systemic delivery IL-33 [4] in inducing tumor-infiltrating eosinophils and CD8 T cells and in delaying tumor growth. The gene discussed is CD8A; the disease is neoplasm.